About Bobak Mozayeni
Form D filings for RheumaGen in 2024 list Bobak Mozayeni as executive officer.
Bobak Mozayeni first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Bobak Mozayeni in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bobak Mozayeni works with at each company, as listed on that company's latest Form D.
RheumaGen, Inc. · Form D, Apr 17, 2024
RH
Ryan Hart
Chief Legal Officer
BG
Bruce Goodwin
Director
TF
Thomas Fratacci
Director
BF
Brian Freed
Executive officer
RI
Richard Freed, III
Executive officer and director
JJ
James Hart, Jr.
Executive officer